PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
07-May-2020 Rothamsted Research answers White House call for coronavirus data help Rothamsted Research
07-May-2020 PTC Therapeutics to Acquire Censa Pharmaceuticals PTC Therapeutics
07-May-2020 MediPharm Labs Australia Granted GMP Certificate and Licence to Manufacture Therapeutic Goods; On Track to Ramp Up and Fulfill New Supply Agreements MediPharm Labs
07-May-2020 Evelo Biosciences, Rutgers University, and Robert Wood Johnson University Hospital Announce Submission of IND for a Phase 2 Study of EDP1815 in COVID-19 Patients Evelo Biosciences, Inc.
07-May-2020 Researchers launch race to develop sustainable COVID-19 vaccine delivery University of Birmingham
07-May-2020 MediPharm Labs Australia Granted GMP Certificate and Licence to Manufacture Therapeutic Goods; On Track to Ramp Up and Fulfill New Supply Agreements MediPharm Labs
07-May-2020 Bone Therapeutics raises additional EUR 4.0 million, totalling EUR 15 million, providing runway into Q2 2021 Bone Therapeutics
07-May-2020 BioNTech Completes Acquisition of Neon Therapeutics BioNTech
06-May-2020 Coronavirus (COVID-19) Update: Daily Roundup U.S. Food and Drug Administration
06-May-2020 AIkido Pharma Executes Artificial Intelligence and Machine Learning Research Agreement with Cogia Biotech LTD AIkido Pharma Inc.
06-May-2020 "Startup as a Masterpiece": Skolkovo Foundation to Hold Startup Village Livestream '20, the Largest Free Virtual International Tech Conference of the Year Skolkovo Foundation
06-May-2020 SCOTTISH LIFE SCIENCE COMPANY DEVELOPS COVID-19 ANTIBODY SCREENING TRIALS TO AID QUEST FOR VACCINE DEVELOPMENT Arrayjet Limited
06-May-2020 Santhera Signs Agreements in Gene Therapy Research for Congenital Muscular Dystrophy with Rutgers University Santhera Pharmaceuticals
06-May-2020 Bone Therapeutics Provides First Quarter 2020 Business Update Bone Therapeutics
06-May-2020 Antabio Receives QIDP Designation from the U.S. FDA for the Development of MEM-ANT3310, a Novel Broad-Spectrum Combination Therapy Targeting WHO’s Priority Pathogens Antabio SAS
06-May-2020 Bavarian Nordic Enters Agreement with AdaptVac to Advance COVID-19 Vaccine Program Bavarian Nordic
06-May-2020 Oxford Biomedica plc Preliminary results for the year ended 31 December 2019 Oxford Biomedica plc
06-May-2020 Farxiga approved in the US for the treatment of heart failure in patients with heart failure with reduced ejection fraction AstraZeneca
06-May-2020 AXON Receives Laureate Award from UK Great Place to Work® AXON Communications
06-May-2020 Trio of Awards for Synergy Vision in Just One (Four-Day-Working) Week … prestigious Platinum from Investors in People, UK’s 3rd Best Small Workplace for 2020 by Great Place to Work® and platinum and gold Muse Creative Awards … Synergy Vision (SV)